Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

81
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
81
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

101
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
101
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

105
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
105
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

161
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
161
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

135
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
135
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

89
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
89

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in echocardiographic left ventricular remodeling and clinical outcomes following transcatheter aortic valve implantation.

Journal of echocardiography·2026
Same author

Impact of a Fully Integrated "1-Click" Automated Left Ventricular Ejection Fraction Tool on Echocardiography Reporting.

CJC open·2026
Same author

EchoAgent: guideline-centric reasoning agent for echocardiography measurement and interpretation.

International journal of computer assisted radiology and surgery·2026
Same author

TREAT-Netv2: regional wall motion-informed video-tabular fusion for ACS treatment prediction.

International journal of computer assisted radiology and surgery·2026
Same author

Optimizing point-of-care ultrasound video acquisition for probabilistic multi-task heart failure detection.

International journal of computer assisted radiology and surgery·2026
Same author

Reframing Diastolic Function: From Classification to Continuous Physiology.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same journal

RETRACTED: Bakshi et al. Crocin Inhibits Angiogenesis and Metastasis in Colon Cancer via TNF-α/NF-kB/VEGF Pathways. <i>Cells</i> 2022, <i>11</i>, 1502.

Cells·2026
Same journal

Correction: Verde et al. Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses. <i>Cells</i> 2025, <i>14</i>, 680.

Cells·2026
Same journal

Inflammation in Cardiomyopathies: Cellular Mechanisms Across Cardiac Phenotype.

Cells·2026
Same journal

IL-4/IL-13-Driven Dysregulation of Epidermal Lipid Metabolism in Atopic Dermatitis: An Immunometabolic Link Between Type 2 Inflammation and Barrier Dysfunction.

Cells·2026
Same journal

Activity of DNA- and RNA-Guided Prokaryotic Argonautes in Human Mitochondria.

Cells·2026
Same journal

Placental Pathophysiology in Maternal Psychoactive Substance Use: Biological, Clinical, and Forensic Perspectives.

Cells·2026
See all related articles

Related Experiment Video

Updated: Oct 30, 2025

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.8K

Fabry Cardiomyopathy: Current Practice and Future Directions.

Jeffrey Yim1, Olivia Yau2, Darwin F Yeung3

  • 1Department of Medicine, University of British Columbia, Vancouver, BC V6H 0A5, Canada.

Cells
|July 2, 2021
PubMed
Summary
This summary is machine-generated.

Fabry disease (FD), a genetic disorder, causes harmful glycosphingolipid buildup. Early detection through advanced diagnostics and new therapies is crucial to prevent irreversible organ damage.

Keywords:
Fabry cardiomyopathyFabry diseaselysosomal storage disorder

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.3K
Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
08:37

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.

Published on: March 3, 2021

4.7K

Related Experiment Videos

Last Updated: Oct 30, 2025

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

7.8K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.3K
Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
08:37

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.

Published on: March 3, 2021

4.7K

Area of Science:

  • Genetics and rare diseases
  • Cardiology
  • Biochemistry

Background:

  • Fabry disease (FD) is an X-linked lysosomal storage disorder resulting from mutations in the galactosidase A (GLA) gene.
  • This genetic defect leads to deficient galactosidase A enzyme activity and the accumulation of glycosphingolipids.
  • FD manifests as a multi-system disorder affecting the skin, eyes, heart, kidneys, and nervous system, with cardiac involvement being prominent.

Purpose of the Study:

  • To highlight the advancements in diagnosing Fabry cardiomyopathy.
  • To emphasize the importance of early diagnosis for effective treatment and prevention of end-organ damage.
  • To discuss emerging diagnostic and therapeutic strategies for Fabry disease.

Main Methods:

  • Utilizing cardiac biomarkers for detection.
  • Employing point-of-care dried blood spot testing.
  • Leveraging advanced imaging modalities like echocardiography with strain imaging and MRI with T1 mapping.

Main Results:

  • Current diagnostic tools enable more effective detection of Fabry cardiomyopathy.
  • Emerging therapies alongside enzyme replacement therapy (ERT) offer new treatment avenues.
  • Initiatives using artificial intelligence (AI) and point-of-care ultrasound aim to improve early diagnosis rates.

Conclusions:

  • Fabry disease can be identified and treated early, before irreversible damage occurs.
  • The perception of FD is shifting from a rare, untreatable condition to one with effective management options.
  • Timely diagnosis is critical for improving patient outcomes and preventing severe complications.